BGM Group Ltd announced the resignation of Mr. Chen Xin as Chairman of the Board and Co-Chief Executive Officer, effective July 30, 2026, citing personal reasons without any dispute with the company. The board appointed his father, Mr. Zhanchang Xin, as the new Chairman of the Board, leveraging over 35 years of pharmaceutical industry experience. Additionally, Ms. Hong Li was appointed as Co-Chief Executive Officer effective July 30, 2026, bringing extensive financial management and accounting expertise from her tenure at Gansu Qilianshan Pharmaceutical Co. Ltd. These leadership changes represent a significant transition in the company's executive structure.

BGM Group Ltd. regained compliance with Nasdaq Listing Rule 5250(c)(1) after filing its Form 20-F annual report for the fiscal year ended September 30, 2025, on July 21, 2026. The Nasdaq Staff confirmed compliance on July 24, 2026, resolving the deficiency that arose from the delayed filing. The company operates in the biotechnology and pharmaceutical industry.

At an extraordinary general meeting on July 9, 2026, shareholders approved resolutions authorizing the board of directors to implement a share consolidation, a post-share consolidation share capital increase, a share capital reduction and reorganization, and the adoption of new Articles of Memorandum and Association. The board is authorized to determine the specific share consolidation ratio within a predefined range and execute these actions for a period of three years. BGM Group Ltd. operates in the gaming and entertainment industry, providing digital content and platform services.

BGM Group Ltd. announced an Extraordinary General Meeting of Shareholders scheduled for July 9, 2026, at 9 p.m. Eastern Time. The meeting will take place at the company's address in Chengdu, China. The filing includes the formal notice and proxy statement for the meeting. BGM Group Ltd. is a company based in China.

BGM Group Ltd closed a private placement on June 8, 2026, issuing 200 million Class A ordinary shares at $0.06 per share and warrants to purchase up to 200 million additional shares. The transaction generated gross proceeds of $12 million. The company operates in the gaming and entertainment industry.